Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 15

1.

Long-term follow-up study of sustained biochemical responders with interferon therapy.

Shindo M, Hamada K, Oda Y, Okuno T.

Hepatology. 2001 May;33(5):1299-302.

PMID:
11343259
2.

The impact of antiviral therapy on the course of chronic HCV infection. A systematic review.

Almasio PL, Venezia G, Craxì A.

Panminerva Med. 2003 Sep;45(3):175-82. Review.

PMID:
14618115
3.

Effect of interferon therapy on the natural history of hepatitis C virus-related cirrhosis and hepatocellular carcinoma.

Poynard T, Moussalli J, Ratziu V, Regimbeau C, Opolon P.

Clin Liver Dis. 1999 Nov;3(4):869-81. Review.

PMID:
11291256
4.

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.

Veldt BJ, Saracco G, Boyer N, Cammà C, Bellobuono A, Hopf U, Castillo I, Weiland O, Nevens F, Hansen BE, Schalm SW.

Gut. 2004 Oct;53(10):1504-8. Review.

5.

Natural history of hepatitis C and the impact of anti-viral therapy.

Boyer N, Marcellin P.

Forum (Genova). 2000 Jan-Mar;10(1):4-18. Review.

PMID:
10717254
6.

Long-term effects of interferon-based therapy for chronic hepatitis C.

Yu ML, Huang CF, Dai CY, Huang JF, Chuang WL.

Oncology. 2007;72 Suppl 1:16-23. Epub 2007 Dec 13. Review.

PMID:
18087178
7.

Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy.

Omata M, Yoshida H, Shiratori Y.

Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S141-3. Review.

PMID:
16234063
8.

Effects of interferon therapy in "non responder" patients with chronic hepatitis C.

Poynard T, Moussali J, Ratziu V, Regimbeau C, Opolon P.

J Hepatol. 1999;31 Suppl 1:178-83. Review.

PMID:
10622583
9.

Interferon therapy as chemoprevention of hepatocarcinogenesis in patients with chronic hepatitis C.

Hino K, Okita K.

J Antimicrob Chemother. 2004 Jan;53(1):19-22. Epub 2003 Dec 4. Review.

10.

Long-term effects of interferon therapy on histology and development of hepatocellular carcinoma in hepatitis C.

Omata M, Shiratori Y.

J Gastroenterol Hepatol. 2000 May;15 Suppl:E134-40. Review.

PMID:
10921397
11.
12.
13.

[Optimal antiviral therapy of chronic hepatitis caused by hepatitis C virus].

Cooreman MP, Stadhouders P.

Orv Hetil. 1997 Jun 1;138(22 Suppl 1):1476-82. Review. Hungarian.

PMID:
9221377
14.

Review article: glycyrrhizin as a potential treatment for chronic hepatitis C.

van Rossum TG, Vulto AG, de Man RA, Brouwer JT, Schalm SW.

Aliment Pharmacol Ther. 1998 Mar;12(3):199-205. Review.

15.

[Treatment options for chronic hepatitis C virus infection].

Bojić I, Dokić L, Minić S.

Med Pregl. 2006 Nov-Dec;59(11-12):560-6. Review. Serbian.

PMID:
17633898
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk